The prenatal morphogenesis of hair follicles depends upon a precisely regulated series of molecular genetic processes. Hormones and their receptors play prominent roles in modulating postnatal hair cycling, which recapitulates some aspects of morphogenesis. The responses to androgen are the most obvious of these. The postnatal androgen sensitivity of pilosebaceous units in different skin areas is programmed during prenatal development to permit clinical outcomes such as hirsutism and pattern baldness. Thyroid hormone, glucocorticoids, insulin-like growth factor-I, and prolactin have clinically significant effects on specific aspects of hair growth. The nuclear receptors vitamin D receptor and retinoid X receptor are essential for postnatal hair cycling. Other hormones have less clear effects on hair growth. Advances in research on the interaction of hormone target genes with the biological processes involved in hair morphogenesis and cycling can be expected to improve management of hirsutism and alopecia.

Keywords:
Alopecia, Androgens, Hair follicle, Hirsutism, Receptor, androgen, Receptor, vitamin D, Sebaceous glands
1.
Deplewski D, Rosenfield RL: Role of hormones in pilosebaceous unit development. Endocr Rev 2000;21:363–392.
2.
Hardy MH: The secret life of the hair follicle. Trends Genet 1992;8:55–61.
3.
Paus R, Muller-Rover S, Van Der Veen C, et al: A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999;113:523–532.
4.
Millar SE: Molecular mechanisms regulating hair follicle development. J Invest Dermatol 2002;118:216–225.
5.
Nakamura M, Sundberg JP, Paus R: Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: Annotated tables. Exp Dermatol 2001;10:369–390.
6.
Oro AE, Scott MP: Splitting hairs: Dissecting roles of signaling systems in epidermal development. Cell 1998;95:575–578.
7.
Widelitz RB, Jiang TX, Noveen A, et al: FGF induces new feather buds from developing avian skin. J Invest Dermatol 1996;107:797–803.
8.
Noramly S, Morgan BA: BMPs mediate lateral inhibition at successive stages in feather tract development. Development 1998;125:3775–3787.
9.
Huelsken J, Vogel R, Erdmann B, et al: β-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001;105:533–545.
10.
Van Genderen C, Okamura RM, Farinas I, et al: Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 1994;8:2691–2703.
11.
Thesleff I, Mikkola ML: Death receptor signaling giving life to ectodermal organs. Sci STKE 2002;2002:PE22.
12.
Gat U, DasGupta R, Degenstein L, Fuchs E: De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 1998;95:605–614.
13.
Chiang C, Swan RZ, Grachtchouk M, et al: Essential role for sonic hedgehog during hair follicle morphogenesis. Dev Biol 1999;205: 1–9.
14.
St-Jacques B, Dassule HR, Karavanova I, et al: Sonic hedgehog signaling is essential for hair development. Curr Biol 1998;8:1058–1068.
15.
Naito A, Yoshida H, Nishioka E, et al: TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci USA 2002;99:8766–8771.
16.
Zheng Y, Eilertsen KJ, Ge L, et al: Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet 1999;23:268–270.
17.
Muller-Rover S, Handjiski B, van der Veen C, et al: A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001;117:3–15.
18.
Taylor G, Lehrer MS, Jensen PJ, et al: Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 2000;102:451–461. 18a Alonso L, Fuchs E: Stem cells in the skin: Waste not, want not. Genes Dev 2003; in press.
19.
Foitzik K, Lindner G, Mueller-Roever S, et al: Control of murine hair follicle regression (catagen) by TGF-β1 in vivo. FASEB J 2000;14:752–760.
20.
Botchkarev VA, Botchkareva NV, Albers KM, et al: A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression. FASEB J 2000;14:1931–1942.
21.
Suzuki S, Ota Y, Ozawa K, Imamura T: Dual-mode regulation of hair growth cycle by two Fgf-5 gene products. J Invest Dermatol 2000;114:456–463.
22.
Milner Y, Sudnik J, Filippi M, et al: Exogen, shedding phase of the hair growth cycle: Characterization of a mouse model. J Invest Dermatol 2002;119:639–644.
23.
Rosenfield RL, Moll GWJ: The role of proteins in the distribution of plasma androgens and estradiol; in Molinatti G, Martini L, James VHT (eds): Androgenization in Women. New York, Raven Press, 1983, pp 25–45.
24.
French FS, Lubahn DB, Brown TR, et al: Molecular basis of androgen insensitivity. Recent Prog Horm Res 1990;46:1–38.
25.
Hoffmann R: Enzymology of the hair follicle. Eur J Dermatol 2001;11:296–300.
26.
Labrie F, Luu-The V, Labrie C, et al: Intracrinology and the skin. Horm Res 2000;54:218–229.
27.
Sawaya ME, Price VH: Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997;109:296–300.
28.
Eicheler W, Happle R, Hoffmann R: 5α-Reductase activity in the human hair follicle concentrates in the dermal papilla. Arch Dermatol Res 1998;290:126–132.
29.
Itami S, Kurata S, Takayasu S: 5α-Reductase activity in cultured human dermal papilla cells from beard compared with reticular dermal fibroblasts. J Invest Dermatol 1990;94:150–152.
30.
Ando Y, Yamaguchi Y, Hamada K, et al: Expression of mRNA for androgen receptor, 5α-reductase and 17β-hydroxysteroid dehydrogenase in human dermal papilla cells. Br J Dermatol 1999;141:840–845.
31.
Sawaya ME, Penneys NS: Immunohistochemical distribution of aromatase and 3β-hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland. J Cutan Pathol 1992;19:309–314.
32.
Poukka H, Karvonen U, Yoshikawa N, et al: The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. J Cell Sci 2000;113:2991–3001.
33.
Yeh S, Sampson ER, Lee DK, et al: Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer. J Formos Med Assoc 2000;99:885–894.
34.
Janne OA, Moilanen AM, Poukka H, et al: Androgen-receptor-interacting nuclear proteins. Biochem Soc Trans 2000;28:401–405.
35.
Roy AK, Tyagi RK, Song CS, et al: Androgen receptor: Structural domains and functional dynamics after ligand-receptor interaction. Ann NY Acad Sci 2001;949:44–57.
36.
McPhaul MJ, Young M: Complexities of androgen action. J Am Acad Dermatol 2001;45(suppl):87–94.
37.
Brinkmann AO: Molecular basis of androgen insensitivity. Mol Cell Endocrinol 2001;179:105–109.
38.
Lu ML, Schneider MC, Zheng Y, et al: Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001;276:13442–13451.
39.
Gupta C, Goldman AS: The arachidonic acid cascade is involved in the masculinizing action of testosterone on embryonic external genitalia in mice. Proc Natl Acad Sci USA 1986;83:4346–4349.
40.
Maor G, Hochberg Z, Silbermann M: Insulin-like growth factor I accelerates proliferation and differentiation of cartilage progenitor cells in cultures of neonatal mandibular condyles. Acta Endocrinol (Copenh) 1993;128:56–64.
41.
Elliott K, Stephenson TJ, Messenger AG: Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: Implications for the control of hair follicle size and androgen responses. J Invest Dermatol 1999;113:873–877.
42.
Choudhry R, Hodgins MB, Van der Kwast TH, et al: Localization of androgen receptors in human skin by immunohistochemistry: Implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992;133:467–475.
43.
Liang T, Hoyer S, Yu R, et al: Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol 1993;100:663–666.
44.
Thornton MJ, Hibberts NA, Street T, et al: Androgen receptors are only present in mesenchyme-derived dermal papilla cells of red deer (Cervus elaphus) neck follicles when raised androgens induce a mane in the breeding season. J Endocrinol 2001;168:401–408.
45.
Hibberts NA, Howell AE, Randall VA: Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998;156:59–65.
46.
Itami S, Kurata S, Sonoda T, Takayasu S: Mechanism of action of androgen in dermal papilla cells. Ann NY Acad Sci 1991;642:385–395.
47.
Randall VA, Hibberts NA, Thornton MJ, et al: Do androgens influence hair growth by altering the paracrine factors secreted by dermal papilla cells? Eur J Dermatol 2001;11:315–320.
48.
Fujie T, Katoh S, Oura H, et al: The chemotactic effect of a dermal papilla cell-derived factor on outer root sheath cells. J Dermatol Sci 2001;25:206–212.
49.
Itami S, Kurata S, Takayasu S: Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor-I from dermal papilla cells. Biochem Biophys Res Commun 1995;212:988–994.
50.
Sonoda T, Asada Y, Kurata S, Takayasu S: The mRNA for protease nexin-1 is expressed in human dermal papilla cells and its level is affected by androgen. J Invest Dermatol 1999;113:308–313.
51.
Lachgar S, Charveron M, Sarraute J, et al: In vitro main pathways of steroid action in cultured hair follicle cells: Vascular approach. J Investig Dermatol Symp Proc 1999;4:290–295.
52.
Kishimoto J, Burgeson RE, Morgan BA: Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev 2000;14:1181–1185.
53.
Dacou-Voutetakis C, Kakourou T: Treatment of atrichia pubis in adolescent girls with pituitary dwarfism. J Pediatr 1996;128:284–285.
54.
Giltay EJ, Gooren LJ: Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 2000;85:2913–2921.
55.
Azziz R, Carmina E, Sawaya ME: Idiopathic hirsutism. Endocr Rev 2000;21:347–362.
56.
Vottero A, Stratakis CA, Ghizzoni L, et al: Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: Skewing of X-chromosome inactivation. J Clin Endocrinol Metab 1999;84:1091–1095.
57.
Calvo RM, Asuncion M, Sancho J, et al: The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. J Clin Endocrinol Metab 2000;85:1735–1740.
58.
Mifsud A, Ramirez S, Yong EL: Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. J Clin Endocrinol Metab 2000;85:3484–3488.
59.
Glickman SP, Rosenfield RL: Androgen metabolism by isolated hairs from women with idiopathic hirsutism is usually normal. J Invest Dermatol 1984;82:62–66.
60.
Falsetti L, Gambera A, Platto C, Legrenzi L: Management of hirsutism. Am J Clin Dermatol 2000;1:89–99.
61.
Olsen EA: Female pattern hair loss. J Am Acad Dermatol 2001;45(suppl):70–80.
62.
Whiting DA: Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol 2001;45(suppl):81–86.
63.
Kaufman KD, Olsen EA, Whiting D, et al: Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998;39:578–589.
64.
Sato T, Tadokoro T, Sonoda T, et al: Minoxidil increases 17β-hydroxysteroid dehydrogenase and 5α-reductase activity of cultured human dermal papilla cells from balding scalp. J Dermatol Sci 1999;19:123–125.
65.
Thai KE, Sinclair RD: Finasteride for female androgenetic alopecia. Br J Dermatol 2002;147:812–813.
66.
Oh HS, Smart RC: An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA 1996;93:12525–12530.
67.
Moverare S, Lindberg MK, Faergemann J, et al: Estrogen receptor α but not receptor β, is involved in the regulation of the hair follicle cycling as well as the thickness of epidermis in male mice. J Invest Dermatol 2002;119:1053–1058.
68.
Stenn KS, Paus R, Filippi M: Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol 1998;110:95.
69.
Smart RC, Oh HS: On the effect of estrogen receptor agonists and antagonists on the mouse hair follicle cycle. J Invest Dermatol 1998;111:175.
70.
Cormia FE: Alopecia from oral contraceptives. JAMA 1967;201:635–637.
71.
Buzdar A, Douma J, Davidson N, et al: Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. J Clin Oncol 2001;19:3357–3366.
72.
Goss PE, Clark RM, Ambus U, et al: Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. Clin Cancer Res 1995;1:287–294.
73.
Niiyama S, Happle R, Hoffmann R: Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. Eur J Dermatol 2001;11:195–198.
74.
Rosenfield RL, Fang VS: The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teenagers. J Pediatr 1974;85:830–837.
75.
Marx SJ, Bliziotes MM, Nanes M: Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf) 1986;25:373–381.
76.
Yoshizawa T, Handa Y, Uematsu Y, et al: Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997;16:391–396.
77.
Li YC, Pirro AE, Amling M, et al: Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997;94:9831–9835.
78.
Li YC, Amling M, Pirro AE, et al: Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets and osteomalacia, but not alopecia, in vitamin D receptor-ablated mice. Endocrinology 1998;139:4391–4396.
79.
Sakai Y, Kishimoto J, Demay MB: Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J Clin Invest 2001;107:961–966.
80.
Reichrath J, Schilli M, Kerber A, et al: Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol 1994;131:477–482.
81.
Kong J, Li XJ, Gavin D, et al: Targeted expression of human vitamin D receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. J Invest Dermatol 2002;118:631–638.
82.
Brooke HC: Hairless mice. J Hered. 1926;17:173–174.
83.
Potter GB, Beaudoin GM 3rd, DeRenzo CL, et al: The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev 2001;15:2687–2701.
84.
Bazzano GS, Terezakis N, Galen W: Topical tretinoin for hair growth promotion. J Am Acad Dermatol 1986;15:880–883, 890–893.
85.
Bazzano G, Terezakis N, Attia H, et al: Effect of retinoids on follicular cells. J Invest Dermatol 1993;101(suppl):138–142.
86.
Li M, Chiba H, Warot X, et al: RXR-α ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001;128:675–688.
87.
Credille KM, Slater MR, Moriello KA, et al: The effects of thyroid hormones on the skin of beagle dogs. J Vet Intern Med 2001;15:539–546.
88.
Ahsan MK, Urano Y, Kato S, et al: Immunohistochemical localization of thyroid hormone nuclear receptors in human hair follicles and in vitro effect of L-triiodothyronine on cultured cells of hair follicles and skin. J Med Invest 1998;44:179–184.
89.
Billoni N, Buan B, Gautier B, et al: Thyroid hormone receptor beta1 is expressed in the human hair follicle. Br J Dermatol 2000;142:645–652.
90.
Aoki N, Ito K, Ito M: μ-Crystallin, thyroid hormone-binding protein, is expressed abundantly in the murine inner root sheath cells. J Invest Dermatol 2000;115:402–405.
91.
Safer JD, Fraser LM, Ray S, Holick MF: Topical triiodothyronine stimulates epidermal proliferation, dermal thickening and hair growth in mice and rats. Thyroid 2001;11:717–724.
92.
Karstila T, Rechardt L, Honkaniemi J, et al: Immunocytochemical localization of glucocorticoid receptor in rat skin. Histochemistry 1994;102:305–309.
93.
Perez P, Page A, Bravo A, et al: Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor. FASEB J 2001;15:2030–2032.
94.
Hayman JA, Danks JA, Ebeling PR, et al: Expression of parathyroid hormone-related protein in normal skin and in tumours of skin and skin appendages. J Pathol 1989;158:293–296.
95.
Pun KK, Arnaud CD, Nissenson RA: Parathyroid hormone receptors in human dermal fibroblasts: Structural and functional characterization. J Bone Miner Res 1988;3:453–460.
96.
Swarthout JT, D’Alonzo RC, Selvamurugan N, Partridge NC: Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 2002;282:1–17.
97.
Lalonde M, Li B, Kline L, et al: Modulation of L-type Ca2+ channels in UMR-106 cells by parathyroid hormone-related protein. Life Sci 2001;70:503–515.
98.
Tovar Sepulveda VA, Shen X, Falzon M: Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology 2002;143:596–606.
99.
Wysolmerski JJ, Broadus AE, Zhou J, et al: Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development. Proc Natl Acad Sci USA 1994;91:1133–1137.
100.
Abdalkhani A, Sellers R, Gent J, et al: Nipple connective tissue and its development: Insights from the K14-PTHrP mouse. Mech Dev 2002;115:63–77.
101.
Foley J, Longely BJ, Wysolmerski JJ, et al: PTHrP regulates epidermal differentiation in adult mice. J Invest Dermatol 1998;111:1122–1128.
102.
Schilli MB, Ray S, Paus R, et al: Control of hair growth with parathyroid hormone (7-34). J Invest Dermatol 1997;108:928–932.
103.
Su HY, Hickford JG, Bickerstaffe R, Palmer BR: Insulin-like growth factor 1 and hair growth. Dermatol Online J 1999;5:1.
104.
Philpott MP, Sanders DA, Kealey T: Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol 1994;102:857–861.
105.
Rudman SM, Philpott MP, Thomas GA, Kealey T: The role of IGF-I in human skin and its appendages: Morphogen as well as mitogen? J Invest Dermatol 1997;109:770–777.
106.
Su HY, Hickford JG, The PH, et al: Increased vibrissa growth in transgenic mice expressing insulin-like growth factor 1. J Invest Dermatol 1999;112:245–248.
107.
Liu JP, Baker J, Perkins AS, et al: Mice carrying null mutations of the genes encoding insulin-like growth factor I and type 1 IGF receptor. Cell 1993;75:59–72.
108.
Blok GJ, de Boer H, Gooren LJ, van der Veen EA: Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin. Clin Endocrinol (Oxf) 1997;47:29–36.
109.
Burren CP, Woods KA, Rose SJ, et al: Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome. Horm Res 2001;55:125–130.
110.
Suliman M, Jenkins R, Ross R, et al: Long-term treatment of acromegaly with the somatostatin analogue SR-lanreotide. J Endocrinol Invest 1999;22:409–418.
111.
Nakauchi Y, Kumon Y, Yamasaki H, et al: Scalp hair loss caused by octreotide in a patient with acromegaly: A case report. Endocr J 1995;42:385–389.
112.
Rosenfield RL: Polycystic ovary syndrome and insulin-resistant hyperinsulinemia. J Am Acad Dermatol 2001;45:S95–S104.
113.
Gebbie FE, Forsyth IA, Arendt J: Effects of maintaining solstice light and temperature on reproductive activity, coat growth, plasma prolactin and melatonin in goats. J Reprod Fertil 1999;116:25–33.
114.
Lincoln GA, Clarke IJ: Role of the pituitary gland in the development of photorefractoriness and generation of long-term changes in prolactin secretion in rams. Biol Reprod 2000;62:432–438.
115.
Craven AJ, Ormandy CJ, Robertson FG, et al: Prolactin signaling influences the timing mechanism of the hair follicle: Analysis of hair growth cycles in prolactin receptor knockout mice. Endocrinology 2001;142:2533–2539.
116.
Nixon AJ, Ford CA, Wildermoth JE, et al: Regulation of prolactin receptor expression in ovine skin in relation to circulating prolactin and wool follicle growth status. J Endocrinol 2002;172:605–614.
117.
Thompson DL Jr, Hoffman R, DePew CL: Prolactin administration to seasonally anestrous mares: Reproductive, metabolic and hair-shedding responses. J Anim Sci 1997;75:1092–1099.
118.
Glickman SP, Rosenfield RL, Bergenstal RM, Helke J: Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. J Clin Endocrinol Metab 1982;55:251–257.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.